Blood pressure management in the kidney transplant recipient

Advances in Chronic Kidney Disease
Matthew R Weir

Abstract

Hypertension is extremely common after kidney transplantation. It has been observed in up to 80% to 90% of patients. The etiologies are multifactorial but, in large part, rest with the native kidneys, concomitant immunosuppressant drugs, and behavioral factors that promote the development of higher levels of blood pressure, including obesity, salt intake, smoking, and alcohol consumption. There is a direct relationship between kidney allograft failure and level of systolic blood pressure during follow-up. Patients with a systolic blood pressure greater than 180 mmHg have 2-fold greater risk of loss of graft function compared with patients with systolics of less than 140 mmHg. A similar pattern exists for diastolic blood pressure. Some investigators have also demonstrated that higher levels of blood pressure also correlate with an increased risk of acute graft rejection, particularly in African Americans. What is not known is whether more effective control of arterial pressure in the transplant patient will reduce the likelihood of graft loss and improve survival. No prospective outcome trials have ever been performed. However, it is likely, given the marked success of better control of blood pressure in nontransplant patients i...Continue Reading

References

Aug 1, 1991·Transplantation·F M ModenaM E Rosenberg
Feb 1, 1991·Transplantation·B L KasiskeK V Rao
Sep 13, 1990·The New England Journal of Medicine·U ScherrerR G Victor
Jan 4, 1996·The New England Journal of Medicine·M J KlagJ Stamler
Sep 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M PerazellaM J Bia
Apr 1, 1995·Kidney International·F G CosioR M Ferguson
May 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·B M Brenner, E L Milford
May 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C PonticelliA Tarantino
Nov 20, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A S Levey
Jan 6, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C E StigantJ S Zaltzman
Feb 9, 2000·JAMA : the Journal of the American Medical Association·K C MangeH I Feldman
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·W ZhangR G Victor
Aug 31, 2000·Journal of the American Society of Nephrology : JASN·Bertram L KasiskeJoseph Roel
Oct 29, 2000·American Journal of Physiology. Renal Physiology·M WalkerL G Navar
Feb 7, 2001·Journal of the American Society of Nephrology : JASN·Gerry LigtenbergHein A Koomans
May 16, 2001·American Journal of Physiology. Renal Physiology·A JustH R Kirchheim
Sep 5, 2001·Kidney International·T H JafarUNKNOWN AIPRD Study Group. Angiotensin-Converting Enzymne Inhibition and Progression of Renal Disease
Sep 22, 2001·The New England Journal of Medicine·E J LewisUNKNOWN Collaborative Study Group
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Mar 6, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Angela Yee Moon WangSiu Fai Lui
Jun 28, 2002·Cleveland Clinic Journal of Medicine·Marvin A Konstam, Matthew R Weir
Jun 28, 2002·Cleveland Clinic Journal of Medicine·Matthew R Weir
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jul 16, 2003·Archives of Internal Medicine·George L BakrisUNKNOWN RENAAL Study Group

❮ Previous
Next ❯

Citations

Nov 6, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Thomas PhilippChristophe Legendre
Aug 20, 2005·Nephrology·Kirsten A ArmstrongNicole M Isbel
Feb 16, 2005·Expert Opinion on Drug Safety·Ali J OlyaeiWilliam M Bennett
Sep 20, 2011·Journal of the American Society of Hypertension : JASH·Matthew R Weir, Daniel J Salzberg
Jan 13, 2011·Advances in Chronic Kidney Disease·Mario F Rubin
Oct 11, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Kirsten A ArmstrongNicole M Isbel
Apr 21, 2016·The Medical Clinics of North America·Mrudula R Munagala, Anita Phancao
Apr 26, 2005·Transplantation·David A J NealGraeme J M Alexander
Feb 22, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Anushree C Shirali, Margaret J Bia
Jan 19, 2005·British Journal of Community Nursing·Vari Drennan, Claire Goodman
Jun 5, 2014·Cardiology in Review·Daniel Glicklich, Parag Vohra
May 17, 2017·Frontiers in Pediatrics·Olga Charnaya, Asha Moudgil

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.